Patient support apparatus including a lateral tilt device

Information

  • Patent Grant
  • 8601622
  • Patent Number
    8,601,622
  • Date Filed
    Friday, April 5, 2013
    11 years ago
  • Date Issued
    Tuesday, December 10, 2013
    10 years ago
Abstract
A lateral tilting device for a patient lying on a mattress is capable of being inserted between the mattress and a level bed base or bed frame on which the mattress rests. The lateral tilting device comprises at least two independent first and second inflatable cells, pneumatically independent and positioned at least partly symmetrically from one another in relation to a median axis of the tilting device. The lateral tilting device includes two ‘U’ shaped inflatable compartments that are fitted into one another. A method for the lateral tilting of the mattress includes inflating a said first or second cell and concomitant deflation of the other second or respectively first cell of the tilting device laid out under the mattress.
Description
BACKGROUND

The present disclosure concerns a support device comprising a mattress capable of supporting a patient in a lying position, as well as a device for laterally tilting said patient thus lying on the mattress. More specifically, this disclosure concerns a lateral tilting device capable of being inserted between said mattress and a base or frame of a bed or chair adapted for medical use upon which it rests.


It is known that a therapeutic support device can comprise a mattress resting or capable of resting on a base or frame, said mattress comprising a plurality of transversal inflatable cells, more or less cylindrical, each extending in a lateral direction perpendicular to the longitudinal direction of the mattress, said transversal cells being laid out side by side in the longitudinal direction of the mattress, the support device moreover comprising the means of inflating said cells and, preferably, the electronic means of regulating the air pressure within said cells, preferably also according to the morphology of the patient lying upon said mattress.


In some such support devices, each cell is equipped in a known manner with an air feed orifice and an air evacuation orifice, which communicate in a substantially airtight manner through hoses and by means of electromagnetic valves opening or closing said orifices, with an inflating device, such as a pump and electronic control devices of said pump and said electromagnetic valves.


The support devices of this type are used as mattresses for caring for patients, because they make it possible to ensure an adequate distribution of the interface pressure, that is to say, a pressure exerted locally by each point of the body on the surface of the mattress, according to the morphology and the position of the patients. Such mattresses specifically make it possible, as a function of the number of inflatable cells implemented, to individually control the pressure and thus the filling of the inflatable cells in the different areas of the mattress in order to obtain a redistribution of the interface pressure suited to the level of each of the parts of the body of a patient and to avoid or reduce the risk of formation of bedsores in a patient at risk, for example in the vulnerable regions of the body, such as the sacrum and the heels.


Theoretically, the ideal comfort of a patient and the optimum vascularization particularly for preventing the formation of bedsores or for reducing localized pain in certain support areas of the body on the mattress, are notably obtained when the support points of the body are redistributed over the surface of the mattress, that is to say, when the pressure exerted by the various areas of the body on the mattress (called “interface pressure”) are more or less identical for all the of the body surface in contact with the mattress and, moreover, if such surface contact of the body with the mattress is as great as possible, which sometimes involves the adapting of the inflatable cells of the mattress under the various parts of the body to control the level of penetration of the body into the various areas of the mattress.


To accomplish this, the air pressure within the inflatable cells sometimes is distributed by controlling the filling/emptying of them according to certain pre-established calculations based on and according to the measurements made with sensors, in, on or under the mattress depending on the type of sensors utilized. Such sensors, known by people skilled in the art, can measure the pressure exerted by the patient's body or the penetration of the patient's body into the given compartments of the mattress, as described for example in the European patent EP 0 676 158 and European patent EP 1 056 372, as well as unpublished patent application FR 09 53758 filed on Jun. 5, 2009 (the US counterpart of which is U.S. application Ser. No. 12/781,426 filed May 17, 2010) describing pressure sensors comprising a capacitive measuring cell, on behalf of the claimant, each of which is hereby incorporated into this description by reference.


The control and regulation of the filling/emptying of the inflatable elements by means of electromagnetic valves also makes it possible to provide support devices functioning in the so-called “alternating pressure mode” in which certain inflatable cells of the support device regularly distributed over the length of the latter are alternately and simultaneously inflated and deflated. For example, one of two cells, or of three, or even of four is deflated/reinflated, then the adjacent cells to the previously deflated then reinflated cells are deflated/reinflated. Thus, each inflatable cell of the support device is successively deflated/reinflated from one cell to another, creating a sort of wave moving in the longitudinal direction of said device back and forth and relieving the interface pressure locally, facilitating at this point the vascularization of the soft tissue at the interface with the surface of the support device.


Some of the prior art support devices, specifically the mattresses, incorporating such inflatable cells consist, for example, of a first layer, the geometry of which in some instances is kept fixed due to the construction and which generally consists of an air mattress, the envelope of which is not elastic or of a foam bed, of a generally constant thickness throughout the mattress, forming a so-called lower mattress. A second layer lies on this, generally called a “therapeutic mattress,” formed by juxtaposing inflatable cells, generally in the form of more or less cylindrical cells or rolls lying extended in a direction perpendicular to the longitudinal direction of the mattress, welded to one another over their length or only connected to one another at their ends in the transversal direction of the mattress. Each of the areas of the therapeutic mattress is equipped with electromagnetic valves and suitable hoses capable of being connected to an inflation and regulating device, generally independent of the mattress. The lower foam mattress layer, when there is such, and the therapeutic mattress layer consisting of inflatable cells are enclosed in a specially adapted slipcover to enable the filling and emptying of the inflatable rolls of the therapeutic mattress through its hoses connected to an attached inflation and regulating device.


Such mattresses with at least a partially inflatable structure make it possible to assist the prevention, and the effective and increased treatment of bedsores and other injuries or pain associated with keeping patients in a lying and nearly immobile position on hospital beds for a prolonged time, specifically through the implementation of alternating cycles of inflation/deflation of the cells of the therapeutic mattress and a use of differentiated inflation pressures of the cells in relation to the different support areas of the patient's body.


It is sometimes desirable to position the patient on their left side or right side, either to provide care, or to prevent the formation of bedsores or to reduce the localized pain in certain support areas of the body on the mattress, by modifying the location of such support zones through the alternate tilting or rotation of the body to one side then to the other. This practice is sometimes established as 30° lateral decubitus [reclining position] as described below.


To this end, attending staff may possibly use the blocks of foam of a specific shape supplied both as accessories or custom-built for each case, or else they use pillows or headboards that are placed in between the mattress and the patient, such that the body forms a 30° angle with the upper surface of the mattress, while benefitting from a back support and without the perineum contacting the mattress. In some instances, the legs are flexed in the area of the hips and the knees and wedged between them by cushions or foam shapes adapted so as to minimize the support risks between the bony projections. The upper leg is positioned behind the lower leg and flexed at 30° at the hip level and 35° at the knee level, for example.


It is known that some such prior art devices do not allow for the inclination of the mattress and to ensure the continuity of therapeutic performance in terms of pressure regulation of the various areas of the mattress, specifically in relation to the supporting side in the area of the bony projections, such as the large trochanter even between the bony projections themselves, particularly the knees and the ankle bones [malleolus], without interfering with the patient's movements, which can likewise compromise the therapeutic benefits sought or his/her safety in the event of a fall or entrapment in the spaces between the mattress and the bed.


Finally, repeated sequences of alternate lateral movements of the patient's body are not easily done and can possibly require, in some instances, attending personnel to be available to see that the patient remains comfortable in a lateral position for several hours. Moreover, it may be difficult to do, depending on the morphology and pathology of the patient, and may even cause a back injury for the attending personnel. Finally depending on the equipment used, for example, with foam forms, hygienic safety can be difficult to maintain and the material used can be lost, damaged or difficult to manage with respect to its storage and monitoring.


SUMMARY

This disclosure provides an improved type of support device, offering a patient functional lateral tilting, that is integrated into the mattress that is safe. It also can be controlled in terms of the incline angle of the mattress on which the patient lies on the one hand, and on the other, capable of being done cyclically according to the durations of the different stages of the cycle of alternated lateral tilting from one side to the other, in a controlled and reliable manner.


To this end, this disclosure offers a device for laterally tilting a patient lying on a mattress, capable of being inserted between said mattress and a bed base or bed frame on which said mattress lies, characterized in that said lateral tilting device comprises at least two first and second inflatable cells, pneumatically independent and positioned at least partially symmetrically to each other in relation to a median axis of said tilting device, the shape in the inflated state being capable of creating a lateral incline of the mattress when a first cell is inflated more than the second cell and a lateral incline sloping in the opposite direction when said second cell is inflated more then said first cell, said tilting device being inserted between the mattress and a bed base or bed frame on which it rests, with a median axis of said tilting device positioned so as to make it roughly coincide with a longitudinal median axis of said mattress.


By “pneumatically independent” herein, it is understood that said cells are capable of being inflated with air or deflated independently and differently from one another and if desired, independently and differently from the inflatable cells comprising said mattress under which the tilting device is inserted.


This disclosure likewise provides a support device comprising a mattress capable of supporting a patient in a lying position and a lateral tilting device according to the disclosed embodiments, the tilting device being laid out under the mattress inserted between a base or frame and the mattress, and said first and second cells extending in the longitudinal direction of the mattress.


Optionally, said mattress includes a plurality of pneumatically independent inflatable transversal cells and extends in a direction perpendicular to the longitudinal direction of the mattress and side by side in the longitudinal direction of the mattress, the pressure within said transversal cells capable of being regulated at a controlled pressure by means of inflation-deflation or electronically, in relation to the air pressure values measured in the cells and the morphology, the position and/or penetration of the patient into the mattress as determined by a sensor inserted between said mattress and said tilting device.


In some embodiments, said morphology and position sensor, for example a capacitive sensor type, is integrated into the mattress and subject to the same tilting as the latter. The morphology and position sensor, for example a capacitive sensor type, can also be capable of automatically determining the tilt angle before it begins. In any event, a support device according to the present disclosure potentially includes a way of controlling the tilt angle either through support information coming from said morphology and position sensor, or by direct measurement of the angle or any other appropriate means.


In some contemplated embodiments, said mattress comprises said transversal cells resting on a lower mattress or a lower layer preferably consisting of cell(s) filled with air, said tilting device being inserted between said bed frame or bed base and under the mattress.


This disclosure likewise provides a lateral tilting method for a support device characterized in that the tilting of said mattress is done by inflating a said first or second cell and concomitant deflating of the other second or respectively first cell of said tilting device laid out under said mattress.


In some embodiments of the lateral tilting device according to this disclosure, each cell includes at least 2 longitudinal form compartments, preferably more or less cylindrically shaped, of the roll type, the two compartments of each said cell of each group not being laid out symmetrically to one another in relation to the median axis of said tilting device, and the compartment of each said first or second cell closest to the median axis of said tilting device having a lower height than that of the other compartment of the same inflated cell, so as to create the lateral incline of the mattress when said tilting device is inserted between said mattress and said bed base or bed frame, with the median axis of said tilting device positioned so as to make it roughly coincide with the medium longitudinal axis of said mattress.


It is therefore possible that, in a lateral tilting method of the support device according to the present disclosure, when each cell of the tilting device includes two compartments, as described above, the height of the small compartment of the inflated cell is higher than the height of the large compartment of the other deflated cell preferably located on the same side of the median axis of the tilting device following the deflation, such that an incline of the mattress is obtained following a concomitant inflation-deflation of the two cells.


Other forms of cells for a tilting device were tested, single large compartments rather than being paired with small compartments and/or large compartments were paired with adjacent small compartments that create a less homogeneous incline of the mattress, which could be harmful to the stability and the safety of the patient, or do not create the sought inclined plane.


More specifically with regard to some embodiments, in a lateral tilting device according to the present disclosure, said first and second cells extend to a length at least equal to ⅔, preferably at least to ¾ of the length of said mattress, more preferably the length of said first and second cells is at least 1.50 m. Such a length of the cells of the tilting device according to some embodiments of this disclosure, extending over almost the entire length of the body of a patient lying on said mattress makes it possible to avoid the risks of twisting with potentially negative effects on the patient in the case of a cell extending over a shorter length.


According to some other aspects and characteristics of a tilting device according to some embodiments contemplated by this disclosure: the compartments of greater height and compartments of lesser height of each of said first and second cells are located on either end of said longitudinal median axis of the tilting device, and the two compartments of the same said first or second cell communicate pneumatically between one another. In other embodiments, the two compartments of each cell can be pneumatically independent.


In some embodiments of a lateral tilting device according to the disclosure, the latter includes two first and second cells joined with one another, said cells each including at least two compartments communicating with one another, the two compartments of each cell defining a ‘U’ with branches laid flat, including in the inflated state:

    • (i) a large external branch or large compartment longer and larger in diameter than a small internal branch or small compartment, said large and small branches being joined and communicating pneumatically with one another through a junction area extending transversally to one of their longitudinal ends,
    • (ii) the two ‘U’s being fitted into one another such that the small branch or small compartment of each cell is inserted between the two branches or compartments of the other cells; the edges of said small branch of each cell are joined with the edges of the two branches of their said junction area of the other cell, and
    • (iii) the small branch and the large branch of each cell being located on either side of the median axis of the tilting device, the adjacent internal longitudinal edges of the two small branches of the two said first and second cells being connected to one another along the median axis of the tilting device.


The embodiments of the type mentioned in the preceding paragraph can potentially be advantageous in terms of the manufacturing cost. For example, the first and second cells can be mechanically unified with one another through heat-sealing lines of two sheets of plastic material or of cloth coated with plastic material, one against the other, or one sheet of plastic material or of cloth coated with plastic material folded on itself, with said heat-sealed lines forming in addition at least two said compartments, communicating with at least two said junction areas extending transversally between each of said compartments of each of the two cells permitting pneumatic communication between the two compartments at one of their longitudinal ends. In another contemplated embodiment, the junction areas between the two compartments are not formed by heat-sealing of said sheets or of plastic material or cloth coated with plastic material, but by a single hose fixed to the sealing orifices on each of the two said compartments at each of the ends of said hose.


In some embodiments having means of inflation-deflation including at least a pump, inflation-deflation orifices of said first and second cells and independent pneumatic means of communication, such as hoses between said pump and said orifices, are provided and said means of inflation includes an automatic electronic regulating device for the alternating inflation-deflation of the two first and second cells capable of controlling the inflation of a cell and concomitant deflation of the other cell, and successively inflating then deflating each said first and second cell according to cycles of different possible durations, such as with time durations from 30 seconds to 4 hours maintaining the inflated state of each cell and maintaining the deflated state.


More specifically, with regard to some embodiments, the respective height of each said first and second cell at the maximum inflation and respectively minimum state permits a said lateral incline of at least 20°, preferably 25°. This incline is sufficient to completely tilt a patient to one side. For example, the convex pumped upper faces of the two compartments are more or less tangent to a straight line inclined with respect to the horizontal with an angle up to at least 20°, preferably 25°, when the lower faces rest on a horizontal plane.


The embodiments according to the present disclosure can likewise be used in an alternated tilting method, wherein an inflation-deflation cycle is implemented for each said first and second cell successively, to perform the lateral tilts of said mattress alternately on each side, the lateral incline of the mattress possibly being tilted at 4 to 8°, to 5 to 7°, with said cells of the tilting device being inflated at a regulated pressure, like the transversal cells of said mattress, said regulated pressure being still differentiated according to the areas of the mattress in the longitudinal direction of said mattress. This allows for an automated sequential lateral releasing of the support points of the patient on the mattress without creating hyper-pressure.


The sensor thus remains activated to regulate the pressure within the mattress, like that within the inflated cell of the tilting device at the determined inflation pressure. And, the morphology and position sensor according to some embodiments of the present disclosure make it possible to ensure the continuity of therapeutic benefits, a low angulation and the safety of the patient at the time of the tilting.


This relatively low angle actually makes it possible to prevent risks of abrasion or cutting the soft tissue of the patient, and an alternating lateral incline of 5 to 7° likewise makes it possible to keep the patient safe, as the risk of falling is not increased with respect to the flat position. Optionally, in this method according to the present disclosure, the alternating tilting cycles are performed with durations of time from 1 to 3 hours, where the inflated state of each of the first and second cells is maintained, and then the first and second cells are maintained in the deflated state.


In each particular implementation mode, said cells may be comprised of plastic material, such as PVC or PU (polyurethane) or of cloth coated with plastic such as PVC or PU.


Additional features, which alone or in combination with any other feature(s), such as those listed above and those listed in the claims, may comprise patentable subject matter and will become apparent to those skilled in the art upon consideration of the following detailed description of various embodiments exemplifying the best mode of carrying out the embodiments as presently perceived.





BRIEF DESCRIPTION OF THE DRAWINGS

The detailed description particularly refers to the accompanying figures in which:



FIG. 1 is a perspective view of a bed comprising a level frame on which rests a tilting device according to the present disclosure inserted between a mattress and said frame, a patient resting lying on said mattress, the tilting device being inflated to produce an incline of said mattress and of said patient.



FIG. 2 is a top plan view of a deflated lateral inclining or tilting device according to the present disclosure, having two first and second cells in the shape of a ‘U’ laid out in a manner fitting into one another, the different longitudinal edges of the two branches, each in a ‘U,’ comprising two compartments of said first and second cells, which are joined with one another by heat-sealing lines of two sheets of plastic material or of cloth coated with plastic material welded one against the other, or a single sheet folded onto itself and welded onto itself in the area of said sealing lines.



FIG. 3 is a diagrammatic sectional view of a device according to FIG. 2, in which the two first and second cells and the two compartments of each of the two first and second cells are inflated (one shown in solid line and one shown in dotted line).



FIG. 4 is a diagrammatic perspective view of an inclining and tilting device according to the present disclosure laid out under the mattress and in which only one of said first and second cells is inflated so as to produce a lateral incline or tilting of one side, a sensor (in phantom) being inserted between said mattress and said tilting device in the area of the sacrum area cells of the mattress.



FIG. 5 is a schematic view of the electronic arrangement principle in which: LPR1 and LPR2 depict the first cell 1 and second cell 2, P1 and P2 depicts the pressure detections and measurements within said cells 1 and 2, V1 and V2 are respectively the electromagnetic feed 4-1 of cell 1 and emptying 4-2 valves of cell 1, V3 and V4 are electromagnetic feed 4-1 of cell 2 and emptying 4-2 valves of cell 2, respectively, V5 and V6 are the control valves at the escape of cell 1, 4-3 and regulation at the escape from cell 2, 4-3, P is the pump enabling the pressure feed of said cells according to the present disclosure, as well as the other cells of the mattress, and S is a noise emission limiter for the patient's comfort.





DETAILED DESCRIPTION


FIG. 1 shows a perspective view of a bed adapted for medical use comprising a level frame 11 mounted on casters 11a, equipped with lateral barriers 12 and on which a therapeutic support device 10 rests, consisting of the following elements:

    • a series of transversal cells extending in the YY′ direction perpendicular to the longitudinal XX′ direction, that is:
      • one or more transversal cells comprising a head area 19, and
      • one or more transversal cells comprising a back support area 15,
    • a plurality of pneumatically and mechanically independent transversal cells juxtaposed one against the other in the longitudinal XX′ direction, comprising a central support area 16, called the “sacrum area,”
    • one or more transversal cells comprising the thigh support area 17, and
    • one or more transversal cells comprising a calf support area 18, and
    • a plurality of pneumatically and mechanically independent transversal cells juxtaposed in parallel one against the other in the longitudinal XX′ direction, comprising an end area for heel support 9, and
    • an area called “retractable area” 8 of variable dimensions, including four pneumatically independent inflatable transversal cells, said area being inserted between the heel area 9 and the calf area 8, so as to be able to position the heel area 9 by translation movement of it with respect to the heels of the patient lying on the bed, as a function of the reduction of number of cells kept in the inflated state in the retractable area 8.


The different cells of areas 19, 15, 16, 17 and 9 are respectively supported by two lower mattresses 13-1 and 13-2, while the calf support area 18 is supported by a service unit 14 containing an air feed pump and electronic means of control of the opening of the electromagnetic air feed and air evacuation valves of the various pneumatically independent cells, as well as the electronic controls for regulating the pressure in relation to the air pressure measurements within the cells and an interface pressure measurement given by a sensor 5 placed in a known manner under the sacrum area, in the space under the lower mattress 13-2 in a central position of the sacrum area 16, enabling the providing of data relating to the morphology of the patient as a function of the penetration of the patient into said mattress, as determined by said sensor. It is particularly possible to use a capacitive sensor as described in application FR-09 53758 filed on Jun. 5, 2009 on behalf of the claimant incorporated in this description as a reference.



FIG. 1 likewise depicts a lateral tipping from the right side of the patient by means of a lateral tilting device according to device 3, which is placed below lower-mattress 13-1, 13-2. This tilting device 3 extends from the head end of the mattress under the head area up to a part of the heel area, which represents an approximate length of 2.10 m here. Actually, the lateral tilting device 3 extends the entire length of the mattress when retractable area 8 is inserted between the calf support area 18 and the heel support area 9 is completely deflated, heel support end area 9 being moved by lateral translation against calf support area 18.



FIGS. 2 and 3 depict lateral tilting device 3 according to this disclosure, including two pneumatically independent air-inflatable first and second cells 1, 2, that is to say each including two air feed 4-1 and evacuation 4-2 orifices and one escape orifice 4-3, making it possible to more precisely regulate the air pressure within each of the two cells. The two first and second cells 1, 2 each include two compartments 1a-1b and 2a-2b extending into the longitudinal X1X′1 direction of tilting device 3 spaced one from the other in the transversal YY′ direction.


The two compartments 1a, 2a, 1b, 2b of each cell 1, 2 exhibit a more or less cylindrical axial shape extending in parallel to the X1X′1 direction with a roughly oval transversal section, as depicted in FIG. 4. Each said first and second cells 1, 2 exhibits a large compartment 1a, 2a and a small compartment 1b, 2b.


Each of these two large compartments 1a, 2a exhibits a maximum dimension in the transversal YY′, direction, I1=47 cm and each said small compartment 1b, 2b exhibits a maximum dimension in the transversal YY′ direction, I2=26 cm. The maximum width dimensions of the large and small compartments given above correspond to the width of the compartment in the completely deflated state, upper and lower faces of each compartment being laid out flat one on top of the other.


It is known that the width of said compartments is progressively reduced as they inflate, such that once said tilting device is inflated with its longitudinal median X1X′1 axis coinciding with the longitudinal median XX′ axis of the mattress, the tilting device does not exceed the width of said mattress.


The fact that the small compartment of each cell is located on the other side of the median X1X′1 axis of the device in relation to the other compartment, with the small compartment of each cell positioned just after the median X1X′1 axis and the large compartment of each cell positioned in the vicinity of the outside edge of the mattress, makes it possible to create an optimal lateral incline of the mattress while preventing the formation of a cup in the area of the median X1X′1 axis of the mattress. Such a cup could be created if the two compartments of each cell were located on the same side in relation to the median axis X1X′1 of said tilting device and thus in relation to the longitudinal median XX′ axis of the mattress.


The large and small compartments of each cell are spaced in the transversal YY′ direction of a length L2. The small compartments 1b and 2b are smaller than the large compartments 1a and 2a of a length L1 of a maximum dimension equal to 30 cm. The large and small compartments of each cell communicate with one another at their longitudinal ends through a transversal junction area 1c, 2c forming two ‘L1’ shaped cells with the two large and small compartments of each cell.


The two ‘U’ cells 1, 2 are fit into one another such that the small branch or small compartment 1b, 2b of each cell 1, 2 is inserted between the two branches or compartments 2a-2b, 1a-1b of the other cell, the edges of said small branch 1b-1, 1b-2 and 2b-1, 2b2 of each cell being joined with the internal longitudinal edges 1a2, 1b2 and 2a2, 2b2 of the 2 branches of the other cell.


A thus designed tilting device is noteworthy, because it can be easily manufactured by heat-sealing two sheets of plastic material or cloth coated with plastic material, together particularly polyurethane coated cloth, such that the weld lines simultaneously define the circumference 3a of the two cells and the connection line between the two cells.


Thus, internal longitudinal edges 1a2 and 2a2 of the large branches 1-2 and 2a are joined to external longitudinal edges 2b1 and 1b1 of small branches 2b and 1b of the other cell. And internal longitudinal edges 1b2 and 2b2 of each small compartment are joined to one another. In addition, internal edge 1c1-2c1 of each transversal junction area 1c, 2c of each cell is joined to the transversal edge 1b3, 2b3 of longitudinal end of the small compartment comprising the small branch of the ‘U’ of the other cell.


The weld line between the two internal edges 1b2, 2b2 of the two small compartments 1b, 2b coincide with the longitudinal median X1X′1 axis of device 3, such that when tilting device 3 is positioned under a mattress 10, causing longitudinal X1X′1 axis of the tilting device to coincide with longitudinal XX′ axis of the mattress with at least one of first and second cells 1, 2 inflated to the maximum, tilting device 3 exhibits a width L slightly less than the width of the mattress, in the space here less than 85 cm, in the maximum inflation position of one of the 2 cells 1 or 2 only, the heights H and h of the large compartments 1a, 2a and small compartments 1b, 2b, being H=30 cm and h=10 cm.



FIG. 4 schematically depicts the lateral tilting, onto the patient's left side achieved by inflating the second cell 2 and deflating the first cell 1. The outside edge 2a-1 of large branch 2a reaches the proximity of the lateral edge closest to the mattress and internal edge 2b2 of small branch 2b reaches the area of the median XX′ axis of mattress 10.


To laterally tilt from the other side, outside edge 1a-1 of large branch 1a of the other cell, reaches the proximity of the lateral edge closest to the mattress and internal edge 1b-2 of small branch 1b of the other cell, which reaches the area of the median action XX′ axis of the mattress.


They are inflated to the maximum to obtain the maximum heights H and h of the large and small compartments of one of the cells to facilitate the complete lateral tilting of a patient onto the one side with an incline of the mattress of α=20 to 25° for the purpose of providing specific care to the patient.


However, this embodiment provides a comfortable method of treating the patient through an alternating lateral tilting procedure by alternate inflation of each of the two first and second cells 1, 2, the other being deflated or in any case less inflated, as is particularly apparent in view of the diagram of FIGS. 3 and 4, wherein to facilitate the tilting, the height of the large compartment after inflation of a first cell is greater than the height of the small compartment of the other less inflated or deflated cell located on the same side of the median X1X′1 axis of the tilting device and particularly since the height of the deflated large compartment of the other cell is smaller than the height of the small compartment of the first inflated cell.


Straight line D1 tangent to the two large and small compartments of each inflated cell form an angle α to the horizontal, of a maximum of 20 to 25°, which is sufficient to produce the complete tilting of a patient onto the side. And, in the case of a treatment for comfort intended solely to alleviate or prevent the risk of appearance of bedsores, alternate tilts with an incline of 5 to 7° of the right side and of the left side are sufficient.



FIG. 5 depicts the skeleton diagram of the electronic wiring, encompassing the two cells 1, 2 of device 3, that the pumps and electromagnetic valves are contained inside service unit 14, whereas the hoses are contained in a distribution duct (not shown) positioned laterally on each side of mattress 10.


It is clear that depending on the degree of inflation of the different cells and according to the internal air pressure within the two cells 1, 2, it is possible to produce a controlled inclining of the bedridden patient on an air mattress regulated at the control pressure; the inflation of the two first and second cells of tilting device 3 according to the present disclosure can be controlled entirely automatically and sequentially.


Tilting device 3 is joined on the under face of mattress 10, if desired of lower mattress 13-1, by a longitudinal zipper (not shown), so that the two X1X′1′ axes of tilting device and XX′ of the mattress coincide. Thus, during inflation (or deflation) only a lateral half of the device, including the large compartment of one cell and the small compartment of the other change their overall width, the large compartment once inflated being always entirely located under the mattress by reduction of its width in conjunction with the increase of its height.


The cycle, that is the time period of maintaining each position, can be controlled automatically. And the pressure of therapeutic mattress 10 can likewise be controlled automatically by means of sensor 5, which remains active even during the lateral tilting, because the overall width of each inflated cell exceeds the longitudinal median XX′ axis of the mattress from the longitudinal lateral edge of the most distant mattress. Patient 20 thus rests the entire time on an active therapeutic surface 10. Barriers 12 and alarms (not shown) can be activated during the cycle time of an alternate tilting procedure to prevent the patient from possibly falling from mattress 10.


Optionally, the two cells 1, 2 can be inflated to the same control pressure as that of mattress 10, in the region of the sacrum area, which is determined and controlled in connection with sensor 5 controlling the immersion of patient 20, specifically an ultra flat and shapeable capacitive sensor, as described in FR 09 53758 (the US counterpart of which is U.S. application Ser. No. 12/781,426).


The purpose of the lateralization controlled by immersion sensor 5 is to reduce the interface pressure of one side of the patient, while ensuring adequate distribution of the support points over the opposite side that carries him/her, while preventing the creation of significant interface pressure points, the lateralization angles α in the in the alternating tilt procedure are small, from 5 to 7°, so as to avoid risks of abrasion and of cutting the soft tissue of the patient 20.


The two large and small compartments of each deflated cell are made virtually flat at the same time through activation of the large-flow electromagnetic valves, the patient's weight serving as additional support.


By default, the stages of the cycle are: lateralization to the right by inflating the first cell 1, reflattening of the first cell 1, lateralization to the left by inflating the second cell 2, reflattening of the first cell 2, and so on.


The time they are maintained in each stage is standardized at 2 hours by default. The sequences and duration times can be customized by the attending personnel, for example, in 30 minute increments.


Certain stages can be eliminated and a following sequence, for example, can be devised for which the right lateralization is maintained for a longer time than the left lateralization, for example 3 hours on one side and 2 hours on the other.


Sensor 5 remains active at the time of the lateralization, because it is dimensionally ultra-thin and shapeable, thus suited to such lateralization.


Sensor 5 can likewise be used to determine and control the value of the incline angle α of tilting device 3 at its maximum inflation pressure corresponding to said control pressure.


Although certain illustrative embodiments have been described in detail above, many embodiments, variations and modifications are possible that are still within the scope and spirit of this disclosure as described herein and as defined in the following claims.

Claims
  • 1. A patient support apparatus comprising a first layer comprising at least one inflatable bladder, anda lateral tilting device for tilting the first layer, the lateral tilting device being positioned beneath the first layer and comprising first and second inflatable cells that are pneumatically independent, wherein each of the first and second inflatable cells are U-shaped and fitted into one another such that a portion of each of the first and second inflatable cells is nested within the U-shape of the other of the first and second cells without the first and second inflatable cells overlapping, wherein a first lateral incline of the first layer is created when the first cell is inflated more than the second cell and a second lateral incline is created with a slope in an opposite direction to that of the first lateral incline when said second cell is inflated more than said first cell, and wherein a median axis of the lateral tilting device intersects each of the first and second inflatable cells.
  • 2. The patient support apparatus of claim 1, wherein each cell of the first and second inflatable cells comprises two compartments with longitudinal shape, the two compartments of each said cell of the first and second inflatable cells being shaped such that each compartment of said first and second cells closest to the median axis of the tilting device have a lower height than that of the other compartment of the same cell of the first and second inflatable cells in the inflated state.
  • 3. The patient support apparatus of claim 2, wherein said first and second inflatable cells extend over a length of at least 1.5 meters.
  • 4. The patient support apparatus of claim 2, wherein the compartments of greater height and the compartments of lesser height of each of said first and second inflatable cells are located on opposite sides of said longitudinal median axis of the lateral tilting device.
  • 5. The patient support apparatus of claim 2, wherein the two compartments of each of the first and second inflatable cells communicate between each other pneumatically.
  • 6. The patient support apparatus of claim 1, wherein the respective height of each said first and second inflatable cells in the maximum and respectively minimum inflation state permits said first and second lateral inclines of about 20° to about 25°.
  • 7. The patient support apparatus of claim 1, wherein the first and second inflatable cells are joined to one another.
  • 8. The patient support apparatus of claim 7, wherein the first and second inflatable cells are joined mechanically to one another by heat-sealing lines of two sheets comprising plastic material, one against the other, or a sheet comprising plastic material folded onto itself, said heat-sealing lines forming the at least two compartments of the first and second inflatable cells.
  • 9. The patient support apparatus of claim 7, further comprising means of inflation-deflation including at least one pump, inflation-deflation orifices of said first and second inflatable cells and means of independent pneumatic communication between said pumps and said orifices, and said means of inflation-deflation comprising an automatic electronic regulating device for alternate inflation-deflation of the first and second inflatable cells capable of controlling the inflation of one cell and concomitant deflation of the other cell and successive inflation, then deflation of each said first and second inflatable cell according to cycles of different durations, with time durations for maintaining the inflated state of each cell and maintaining the deflated state from about 30 seconds to about 4 hours.
  • 10. The patient support apparatus of claim 1, wherein said first and second inflatable cells comprise a plastic material including at least one of PVC or PU (polyurethane).
  • 11. The patient support apparatus of claim 1, wherein the first and second inflatable cells are located entirely within a footprint of the upper layer when viewed from above.
  • 12. The patient support apparatus of claim 1, wherein the at least one bladder of the upper layer comprises a plurality of pneumatically independent inflatable transversal cells extending in a direction perpendicular to a longitudinal direction of the upper layer and side by side in the longitudinal direction of the upper layer.
  • 13. The patient support apparatus of claim 12, wherein a pressure within the transversal cells is regulated by inflation and deflation according to air pressure values measured in the cells and a position and/or penetration of a patient into the upper layer as determined by a sensor situated between the upper layer and the lateral tilting device.
  • 14. The patient support apparatus of claim 12, wherein the plurality of transversal cells of the upper layer rests on a lower layer comprising air filled cells, the lateral tilting device being situated beneath the lower layer.
Priority Claims (1)
Number Date Country Kind
09 55935 Aug 2009 FR national
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. application Ser. No. 12/856,076, filed Aug. 13, 2010, which claims priority, under 35 U.S.C. §119(a), of French National Application No. 0955935 which was filed Aug. 31, 2009 and each of which is hereby incorporated by reference herein.

US Referenced Citations (204)
Number Name Date Kind
624638 Fournier May 1899 A
1147560 Shurtleff Jul 1915 A
1468072 Ogle Sep 1923 A
1772310 Hart Aug 1930 A
2245909 Enfiajian Jun 1941 A
2415150 Stein Feb 1947 A
2437006 Simpson Mar 1948 A
2460245 Summerville Jan 1949 A
2491557 Goolsbee Feb 1949 A
2575764 Morner Nov 1951 A
2604641 Reed Jul 1952 A
2719986 Rand Oct 1955 A
2998817 Armstrong Sep 1961 A
3148391 Whitney Sep 1964 A
3192540 Swank Jul 1965 A
3199124 Grant Aug 1965 A
3297023 Foley Jan 1967 A
3303518 Ingram Feb 1967 A
3317934 Hinrichs May 1967 A
3363941 Wierwille Jan 1968 A
3390674 Jones Jul 1968 A
3394415 Parker Jul 1968 A
3421163 Stoughton Jan 1969 A
3426373 Scott et al. Feb 1969 A
3446203 Murray May 1969 A
3462778 Whitney Aug 1969 A
3467081 Glass Sep 1969 A
3477071 Emerson Nov 1969 A
3485240 Fountain Dec 1969 A
3492988 DeMare Feb 1970 A
3587568 Thomas Jun 1971 A
3595223 Castagna Jul 1971 A
3605138 Tucker Sep 1971 A
3605145 Graebe Sep 1971 A
3644950 Lindsay, Jr. Feb 1972 A
3653083 Lapidus Apr 1972 A
3667073 Renfroe Jun 1972 A
3670347 Weinstein Jun 1972 A
3674019 Grant Jul 1972 A
3678520 Evans Jul 1972 A
3701173 Whitney Oct 1972 A
3740777 Dee Jun 1973 A
3757356 Freeman Sep 1973 A
3762404 Sakita Oct 1973 A
3775781 Bruno et al. Dec 1973 A
3784994 Kery Jan 1974 A
3795021 Moniot Mar 1974 A
3822425 Scales Jul 1974 A
3867732 Morrell Feb 1975 A
3870450 Graebe Mar 1975 A
3879776 Solen Apr 1975 A
3909858 Ducker Oct 1975 A
3919730 Regan Nov 1975 A
3935604 Collins Feb 1976 A
3949438 Scales Apr 1976 A
3955563 Maione May 1976 A
3978530 Amarantos Sep 1976 A
3982786 Burgin et al. Sep 1976 A
4005236 Graebe Jan 1977 A
4068334 Randall Jan 1978 A
4094025 Nystad Jun 1978 A
4099276 Hunt et al. Jul 1978 A
4132228 Green Jan 1979 A
4136413 Scales Jan 1979 A
4149285 Stanton Apr 1979 A
4175297 Robbins et al. Nov 1979 A
4185341 Scales Jan 1980 A
4190286 Bentley Feb 1980 A
4193149 Welch Mar 1980 A
4197837 Tringali et al. Apr 1980 A
4225989 Corbett et al. Oct 1980 A
4267611 Agulnick May 1981 A
4279044 Douglas Jul 1981 A
4280487 Jackson Jul 1981 A
4347633 Gamoons et al. Sep 1982 A
4391009 Schild et al. Jul 1983 A
4422194 Viesturs et al. Dec 1983 A
4428087 Horn Jan 1984 A
4454615 Whitney Jun 1984 A
4472847 Gammons et al. Sep 1984 A
4483030 Flick et al. Nov 1984 A
4488322 Hunt et al. Dec 1984 A
4508107 Strom et al. Apr 1985 A
4517693 Viesturs May 1985 A
4525885 Hunt et al. Jul 1985 A
4525886 Savenije Jul 1985 A
4527298 Moulton Jul 1985 A
4528704 Wegener et al. Jul 1985 A
4534078 Viesturs et al. Aug 1985 A
4541136 Graebe Sep 1985 A
4542547 Sato Sep 1985 A
4551874 Matsumura et al. Nov 1985 A
4583255 Mogaki et al. Apr 1986 A
4594743 Owen et al. Jun 1986 A
4614000 Mayer Sep 1986 A
4617690 Grebe Oct 1986 A
4622706 Takeuchi Nov 1986 A
4638516 Vrzalik Jan 1987 A
4638519 Hess Jan 1987 A
4642825 Kurita Feb 1987 A
4653130 Senoue et al. Mar 1987 A
4654903 Chubb et al. Apr 1987 A
4662012 Torbet May 1987 A
4686719 Johnson et al. Aug 1987 A
4686722 Swart Aug 1987 A
4688283 Jacobson et al. Aug 1987 A
4694520 Paul et al. Sep 1987 A
4697290 Alklind et al. Oct 1987 A
4698864 Graebe Oct 1987 A
4700418 Ritter Oct 1987 A
4711275 Ford et al. Dec 1987 A
4722105 Douglas Feb 1988 A
4729598 Hess Mar 1988 A
4745647 Goodwin May 1988 A
4768249 Goodwin Sep 1988 A
4797962 Goode Jan 1989 A
4798227 Goodwin Jan 1989 A
4799276 Kadish Jan 1989 A
4803744 Peck et al. Feb 1989 A
4825486 Kimura et al. May 1989 A
4838309 Goodwin Jun 1989 A
4840425 Noble Jun 1989 A
4852195 Schulman Aug 1989 A
4862921 Hess Sep 1989 A
4864671 Evans Sep 1989 A
4896389 Chamberland Jan 1990 A
4907308 Leininger et al. Mar 1990 A
4914760 Hargest et al. Apr 1990 A
4914771 Afeyan Apr 1990 A
4935968 Hunt et al. Jun 1990 A
4941221 Kanzler Jul 1990 A
4942635 Hargest et al. Jul 1990 A
4944060 Peery Jul 1990 A
4949412 Goode Aug 1990 A
4949413 Goodwin Aug 1990 A
4949414 Thomas et al. Aug 1990 A
4953247 Hasty Sep 1990 A
4962552 Hasty Oct 1990 A
4967431 Hargest et al. Nov 1990 A
5003654 Vrzalik Apr 1991 A
5005240 Vrzalik Apr 1991 A
5008965 Vrzalik Apr 1991 A
5022110 Stroh Jun 1991 A
5029352 Hargest et al. Jul 1991 A
5035014 Blanchard Jul 1991 A
5036559 Hargest Aug 1991 A
5044029 Vrzalik Sep 1991 A
5051673 Goodwin Sep 1991 A
5052067 Thomas et al. Oct 1991 A
5062167 Thomas et al. Nov 1991 A
5065464 Blanchard et al. Nov 1991 A
5065466 Thomas et al. Nov 1991 A
5073999 Thomas et al. Dec 1991 A
5090074 Scales et al. Feb 1992 A
5090077 Caden et al. Feb 1992 A
5092007 Hasty Mar 1992 A
5095568 Thomas et al. Mar 1992 A
5111544 Graebe May 1992 A
5121513 Thomas et al. Jun 1992 A
5138729 Ferrand Aug 1992 A
5142719 Vrzalik Sep 1992 A
5152021 Vrzalik Oct 1992 A
5152023 Graebe Oct 1992 A
5163196 Graebe et al. Nov 1992 A
5168589 Stroh Dec 1992 A
5182826 Thomas et al. Feb 1993 A
5235713 Guthrie Aug 1993 A
5249318 Loadsman Oct 1993 A
5251349 Thomas et al. Oct 1993 A
5269030 Pahno et al. Dec 1993 A
5323500 Roe et al. Jun 1994 A
5373595 Johnson et al. Dec 1994 A
5375273 Bodine, Jr. et al. Dec 1994 A
5388292 Stinson Feb 1995 A
5396671 Stacy Mar 1995 A
5421044 Steenson Jun 1995 A
5487196 Wilkinson et al. Jan 1996 A
5586346 Stacy et al. Dec 1996 A
5611096 Bartlett et al. Mar 1997 A
5926883 Rechin et al. Jul 1999 A
5983428 Hannagan Nov 1999 A
5983429 Stacy et al. Nov 1999 A
6021533 Ellis et al. Feb 2000 A
6145142 Rechin et al. Nov 2000 A
6216300 Hannagan Apr 2001 B1
6295675 Ellis et al. Oct 2001 B1
6421858 Cuerel Jul 2002 B1
6467113 Ellis et al. Oct 2002 B2
6536056 Vrzalik et al. Mar 2003 B1
6584628 Kummer et al. Jul 2003 B1
6760939 Ellis et al. Jul 2004 B2
6904631 Vrzalik et al. Jun 2005 B2
7076818 Kummer et al. Jul 2006 B2
7111348 Ellis et al. Sep 2006 B2
7322947 Flick et al. Jan 2008 B2
7346945 Phillips et al. Mar 2008 B2
7353556 Ellis et al. Apr 2008 B2
7398573 Ellis et al. Jul 2008 B2
7469436 Meyer et al. Dec 2008 B2
7698765 Bobey et al. Apr 2010 B2
7802332 Kummer et al. Sep 2010 B2
8429774 Tarsaud et al. Apr 2013 B2
20070143928 Biggie et al. Jun 2007 A1
20080271253 Pile Nov 2008 A1
Foreign Referenced Citations (73)
Number Date Country
2249013 Jul 1974 DE
7522889 Nov 1975 DE
2446935 Apr 1976 DE
7334397 Sep 1976 DE
2522863 Nov 1976 DE
7639097 Jul 1977 DE
2614861 Oct 1977 DE
2816642 Oct 1978 DE
2919438 Nov 1980 DE
3217981 Nov 1982 DE
3303615 Aug 1984 DE
3535374 Apr 1987 DE
3716263 Nov 1988 DE
9010880 Feb 1991 DE
0 162 785 Nov 1958 EP
0 034 954 Sep 1981 EP
0 122 666 Oct 1984 EP
0 134 051 Mar 1985 EP
0 168 213 Jan 1986 EP
0 228 233 Jul 1987 EP
0 261 830 Mar 1988 EP
0 275 618 Jul 1988 EP
0 296 689 Dec 1988 EP
0 302 579 Feb 1989 EP
0 311 993 Apr 1989 EP
0 338 472 Oct 1989 EP
0 676 158 Oct 1995 EP
1 056 372 Dec 2000 EP
122806 Feb 1919 GB
762528 Nov 1956 GB
796746 Jun 1958 GB
946831 Jan 1964 GB
949652 Feb 1964 GB
958651 May 1964 GB
959103 May 1964 GB
969367 Sep 1964 GB
1023097 Mar 1966 GB
1059100 Feb 1967 GB
1118740 Jul 1968 GB
1126364 Sep 1968 GB
1222710 Feb 1971 GB
1273342 May 1972 GB
1286197 Aug 1972 GB
1291015 Sep 1972 GB
1341325 Dec 1973 GB
1398544 Jun 1975 GB
1440193 Jun 1976 GB
1442994 Jul 1976 GB
1474018 May 1977 GB
1483045 Aug 1977 GB
1499938 Feb 1978 GB
1545806 May 1979 GB
2026315 Feb 1980 GB
1576641 Oct 1980 GB
2059256 Apr 1981 GB
1595417 Aug 1981 GB
1599422 Sep 1981 GB
1601808 Nov 1981 GB
1602952 Nov 1981 GB
2090734 Jul 1982 GB
2107197 Apr 1983 GB
2108837 May 1983 GB
2134382 Aug 1984 GB
2141333 Dec 1984 GB
2167293 May 1986 GB
2177594 Jan 1987 GB
2177595 Jan 1987 GB
2177906 Feb 1987 GB
2183471 Jun 1987 GB
WO 8404884 Dec 1984 WO
WO 8605973 Oct 1986 WO
WO 86-06624 Nov 1986 WO
WO 8903203 Apr 1989 WO
Continuations (1)
Number Date Country
Parent 12856076 Aug 2010 US
Child 13857170 US